Page last updated: 2024-08-24

carbogen and tirapazamine

carbogen has been researched along with tirapazamine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, JM; Dorie, MJ; Menke, D1
Guichard, M; Stern, S1
Brown, JM; Dorie, MJ; el-Said, A; Menke, D1
Kyle, AH; Minchinton, AI; Sutherland, DP; Tonn, DA1
Baker, JH; Huxham, LA; Kyle, AH; McNicol, KL; Minchinton, AI1

Other Studies

5 other study(ies) available for carbogen and tirapazamine

ArticleYear
Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    International journal of radiation oncology, biology, physics, 1994, Jan-01, Volume: 28, Issue:1

    Topics: Animals; Antineoplastic Agents; Carbon Dioxide; Combined Modality Therapy; Drug Combinations; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Niacinamide; Oxygen; Radiation-Sensitizing Agents; Tirapazamine; Triazines

1994
Efficacy of agents counteracting hypoxia in fractionated radiation regimes.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1996, Volume: 41, Issue:2

    Topics: Adenocarcinoma; Animals; Carbon Dioxide; Cell Hypoxia; Emulsions; Female; Fluorocarbons; Humans; Hydrocarbons, Brominated; Mammary Neoplasms, Experimental; Mice; Niacinamide; Oxygen; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy; Radiotherapy Dosage; Rectal Neoplasms; Tirapazamine; Triazines; Tumor Cells, Cultured

1996
Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
    Radiation oncology investigations, 1999, Volume: 7, Issue:3

    Topics: Animals; Carbon Dioxide; Carcinoma, Squamous Cell; Cell Survival; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Models, Animal; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Female; Humans; Male; Mice; Mice, SCID; Neoplasm Transplantation; Niacinamide; Oxygen; Oxygen Consumption; Pharyngeal Neoplasms; Radiation Dosage; Radiation-Sensitizing Agents; Sensitivity and Specificity; Tirapazamine; Triazines; Tumor Cells, Cultured

1999
Carbogen breathing after irradiation enhances the effectiveness of tirapazamine in SiHa tumors but not SCCVII tumors in mice.
    Radiation research, 2002, Volume: 158, Issue:1

    Topics: Administration, Inhalation; Animals; Carbon Dioxide; Carcinoma, Squamous Cell; Drug Synergism; Female; Gamma Rays; Humans; Mice; Mice, Inbred C3H; Mice, SCID; Oxygen; Radiation-Sensitizing Agents; Tirapazamine; Triazines; Uterine Cervical Neoplasms

2002
Exploring vascular dysfunction caused by tirapazamine.
    Microvascular research, 2008, Volume: 75, Issue:2

    Topics: Animals; Antineoplastic Agents; Carbon Dioxide; Cell Hypoxia; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; HCT116 Cells; Humans; Mice; Mice, Inbred C3H; Mice, Inbred NOD; Mice, SCID; Necrosis; Neoplasms, Experimental; Nitric Oxide Synthase; Nitroarginine; Oxygen; Regional Blood Flow; Time Factors; Tirapazamine; Triazines

2008